SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-025849
Filing Date
2024-03-05
Accepted
2024-03-05 16:01:16
Documents
2
Period of Report
2024-02-29

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1608
2 EX-24 ikna-ex24.htm EX-24 11150
  Complete submission text file 0000950170-24-025849.txt   14175
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Issuer) CIK: 0001835579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address IKENA ONCOLOGY, INC. 645 SUMMER STREET, SUITE 101 BOSTON MA 02210
Business Address
Germa Caroline (Reporting) CIK: 0002013288 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40287 | Film No.: 24720149